| Absorption |
| Blood-Brain Barrier | BBB- | 0.9941 |
| Human Intestinal Absorption | HIA- | 0.8626 |
| Caco-2 Permeability | Caco2- | 0.6840 |
| P-glycoprotein Substrate | Substrate | 0.9277 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.5930 |
| Non-inhibitor | 0.9433 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8661 |
| Distribution |
| Subcellular localization | Lysosome | 0.7257 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8436 |
| CYP450 2D6 Substrate | Non-substrate | 0.8180 |
| CYP450 3A4 Substrate | Substrate | 0.6034 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8488 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7380 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8703 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6910 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.6542 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9419 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9983 |
| Inhibitor | 0.6694 |
| AMES Toxicity | Non AMES toxic | 0.7817 |
| Carcinogens | Non-carcinogens | 0.7623 |
| Fish Toxicity | High FHMT | 0.9875 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9685 |
| Honey Bee Toxicity | Low HBT | 0.7442 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.5884 |
| Carcinogenicity (Three-class) | Non-required | 0.6290 |